Emrocef-S 375 Injection
Marketer
Apikos Pharma
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Emrocef-S 375 Injection
Cefixime and Sulbactam injection, a dual-action antibiotic, combats various bacterial infections by inhibiting microbial growth and propagation. Administration should strictly adhere to a healthcare provider's instructions. Complete the prescribed course, even with symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects necessitate immediate medical consultation. Allergic reactions (rash, itching, edema, dyspnea) require urgent medical attention. Inform your physician of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should seek medical advice before use. Alcohol consumption may heighten drowsiness. While generally non-impairing to driving ability, avoid driving if experiencing drowsiness or dizziness. Adequate rest, a nutritious diet, and ample hydration promote recovery. Your doctor might order tests to monitor the medication's effects.
Uses of Emrocef-S 375 Injection
Infections caused by bacteria
Major Benefits of Emrocef-S 375 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Emrocef-S 375 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Emrocef-S 375 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Emrocef-S 375 Injection works:
Ceftriaxone and Sulbactam, the active components of Emrocef-S 375 Injection, work synergistically to combat bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial defenses, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Emrocef-S 375 Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Emrocef-S 375 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human subjects are scarce.
Breast feedingCAUTION
Cefuroxime axetil injection (e.g., Emrocef-S 375) requires careful consideration during lactation. Mothers should temporarily discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The injection Emrocef-S 375 may cause drowsiness, visual disturbances, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Emrocef-S 375 Injection administration to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
For patients exhibiting severe hepatic impairment, the administration of Emrocef-S 375 Injection requires careful monitoring and potential dosage modification. In cases of mild to moderate liver dysfunction, altering the Emrocef-S 375 Injection dosage is not advised. Physician consultation is recommended.
What if you forget to take Emrocef-S 375 Injection :
Omit a dose of Emrocef-S 375 Injection? Seek your physician's advice.
Facts to Know About Emrocef-S 375 Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Treatment Category | Drugs to combat infection |
3,018 People bought this recently